SNX7 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.905600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.980000E-01
Normal-vs-Stage2
4.675600E-01
Normal-vs-Stage3
9.527400E-01
Normal-vs-Stage4
3.071400E-01
Stage1-vs-Stage2
6.471600E-01
Stage1-vs-Stage3
6.772000E-01
Stage1-vs-Stage4
3.133200E-01
Stage2-vs-Stage3
3.414000E-01
Stage2-vs-Stage4
3.203000E-01
Stage3-vs-Stage4
1.119220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.267600E-01
Normal-vs-AfricanAmerican
3.392800E-01
Normal-vs-Asian
7.299200E-01
Caucasian-vs-AfricanAmerican
2.378600E-01
Caucasian-vs-Asian
6.622400E-01
AfricanAmerican-vs-Asian
2.145200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.944800E-01
Normal-vs-Female
3.913400E-01
Male-vs-Female
3.325000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.953800E-01
Normal-vs-Age(41-60Yrs)
2.502600E-01
Normal-vs-Age(61-80Yrs)
6.636600E-01
Normal-vs-Age(81-100Yrs)
4.882800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.766600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.604000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.493800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.863980E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.933800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.356600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.215800E-01
Normal-vs-Daily Drinker
6.854200E-01
Normal-vs-Weekly Drinker
9.599200E-01
Normal-vs-Occasional Drinker
9.796200E-02
Normal-vs-Social Drinker
5.134000E-01
Non Drinker-vs-Daily Drinker
3.857000E-01
Non Drinker-vs-Weekly Drinker
7.568400E-01
Non Drinker-vs-Occasional Drinker
5.796100E-04
Non Drinker-vs-Social Drinker
1.561640E-01
Daily Drinker-vs-Weekly Drinker
3.594000E-01
Daily Drinker-vs-Occasional Drinker
4.113600E-02
Daily Drinker-vs-Social Drinker
6.293800E-01
Weekly Drinker-vs-Occasional Drinker
1.558720E-03
Weekly Drinker-vs-Social Drinker
1.647160E-01
Occasional Drinker-vs-Social Drinker
1.405760E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.285800E-01
Normal-vs-Grade 2
1.184440E-01
Normal-vs-Grade 3
1.312430E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.064340E-03
Grade 1-vs-Grade 3
3.138000E-03
Grade 1-vs-Grade 4
6.285800E-01
Grade 2-vs-Grade 3
8.092200E-01
Grade 2-vs-Grade 4
1.184440E-01
Grade 3-vs-Grade 4
1.312430E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.653800E-01
Normal-vs-NonDiabetic
4.565200E-01
Diabetic-vs-NonDiabetic
1.911230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.733200E-01
Normal-vs-NoPancreatitis
5.362200E-01
Pancreatitis-vs-NoPancreatitis
3.497800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.686600E-01
Normal-vs-N1
4.477000E-01
N0-vs-N1
5.279000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.842300E-02
Normal-vs-TP53-NonMutant
5.974000E-01
TP53-Mutant-vs-TP53-NonMutant
4.435400E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
